Connect Biopharma

Connect Biopharma is a clinical-stage biopharmaceutical company headquartered in San Diego, California, dedicated to transforming care for patients with inflammatory diseases such as asthma and COPD. Its lead drug candidate, rademikibart (CBP-201), is an antibody targeting IL-4Ra in Phase 2 clinical development for acute asthma and COPD exacerbations. Surfaced as a portfolio company of the venture firm Qiming and added to the API Evangelist network, the company operates in the pharmaceutical and biotechnology sector and publishes no public developer portal, API, or technical documentation.

Connect Biopharma is profiled on the APIs.io network. Tagged areas include Company, Biopharmaceutical, Pharmaceuticals, Biotechnology, and Clinical-Stage.

Connect Biopharma’s developer surface includes support, engineering blog, and 4 more developer resources.

🌐 Visit website 📡 Source on GitHub

12.3/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyBiopharmaceuticalPharmaceuticalsBiotechnologyClinical-StageInflammatory DiseasesRespiratoryAsthmaCOPD

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 12.3/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 1.3 / 20

Commercial Clarity 4.2 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/connectbiopharm: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

TermsOfService

TermsOfService

Company 2

The organization behind the API

Website

Website

Blog

Blog

Source (apis.yml)

aid: connectbiopharm
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/connectbiopharm.png
name: Connect Biopharma
description: Connect Biopharma is a clinical-stage biopharmaceutical company headquartered in San Diego, California, dedicated
  to transforming care for patients with inflammatory diseases such as asthma and COPD. Its lead drug candidate, rademikibart
  (CBP-201), is an antibody targeting IL-4Ra in Phase 2 clinical development for acute asthma and COPD exacerbations. Surfaced
  as a portfolio company of the venture firm Qiming and added to the API Evangelist network, the company operates in the pharmaceutical
  and biotechnology sector and publishes no public developer portal, API, or technical documentation.
url: https://raw.githubusercontent.com/api-evangelist/connectbiopharm/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- qiming
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Biopharmaceutical
- Pharmaceuticals
- Biotechnology
- Clinical-Stage
- Inflammatory Diseases
- Respiratory
- Asthma
- COPD
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/connectbiopharm-domain-security.yml
- type: Website
  url: https://www.connectbiopharma.com
- type: PrivacyPolicy
  url: https://www.connectbiopharma.com/privacy-policy
- type: TermsOfService
  url: https://www.connectbiopharma.com/terms-and-conditions
- type: Support
  url: https://www.connectbiopharma.com/contact
- type: Blog
  url: https://www.connectbiopharma.com/news-media
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence